EVAg

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.351 Beta). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2022, GERMANY (LINEAGE BA.5, OMICRON). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.621, Mu). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.318). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2020, GERMANY (LINEAGE B.1). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.7 Alpha). Extracted from infectious cell culture supernatant. Product only available via TNA.

RNA SARS-CoV-2 strain B.1.617 (India). Product only available via TNA.

This product represents cDNA material, transcribed with random hexamers from total RNA extracted from the viral stock of SARS-CoV-2 strain Slovakia/SK-BMC5/2020 which is available as a viable virus under Ref-SKU: 006V-03933.

Inactivated cell culture supernatant containing SARS-CoV-2 (hCoV-19/Netherlands/NH-RIVM-27142/2021, Delta variant). Virus was heat-inactivated for 2 hours at 60C. This strain is preserved in viral storage medium -80°C.

Vial containing RNA of SARS-CoV-2 (hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529. This strain has been cultivated on Calu-3 cells. . GSAID reference: hCoV-19/Netherlands/NH-RIVM-71084/2021.

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the E gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the RdRP gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

RNA extracted from infected cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK))

RNA extracted from infected cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429).

RNA extracted from infected cell culture supernatant containing SARS-CoV-2 strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2.

RNA extracted from infected cell culture supernatant containing SARS-CoV-2 strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2.

RNA extracted from infected cell culture supernatant containing SARS-CoV-2 strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1.

RNA extracted from infected cell culture supernatant containing SARS-CoV-2 strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351).

This product represents total RNA extracted from the viral stock of SARS-CoV-2 strain Slovakia/SK-BMC5/2020 which is available as a viable virus under Ref-SKU: 006V-03933.

In vitro transcribed RNA for a specific SARS-coronavirus real time PCR.

In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region upstream of the E gene (upE). Reference: Corman et. Al., Eurosurveillance, Volume 17, Issue 39, 27 September 2012

In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region within the open reading frame 1a. Reference: Corman/Mueller et al., Eurosurveillance, Volume 17, Issue 49, 06 December 2012

N-terminal domain of the SARS-CoV-2 nucleprotein (1-180). Pure recombinant protein produced in E. coli and fused with a Avi tag and a Hexa-Hisitidine tag.

C-terminal domain of the SARS-CoV-2 nucleprotein (247-418). Pure recombinant protein produced in E. coli and fused with a Avi tag and a Hexa-Hisitidine tag.